Recombinant TSPAN16 is synthesized using:
E. coli systems for bacterial expression, often with N-terminal His-tags for purification .
Lentiviral vectors (e.g., pLTC) for mammalian cell expression, enabling stable integration into host genomes .
TSPAN16 serves as a tool for studying:
Scaffolding roles: Organizes membrane microdomains (TEMs) with integrins, ADAM10, and other tetraspanins (e.g., CD81, CD9) .
Signaling regulation: Modulates pathways like PI3K/Akt, ERK, and Wnt/β-catenin, influencing cell proliferation and migration .
Neurological disorders: Linked to spastic paraplegia (OMIM 617580) and corpus callosum agenesis with peripheral neuropathy .
Cancer: While not directly studied in TSPAN16, tetraspanins like TSPAN1 and TSPAN15 are implicated in hepatocellular carcinoma (HCC) and pancreatic cancer (PC) via autophagy and integrin signaling .
Antibody-based capture: Recombinant TSPAN16 fragments aid in developing antibodies for circulating tumor cell detection (e.g., mucin16, EpCAM) .
Gene therapy: siRNA targeting TSPAN16 homologs (e.g., TSPAN1) in HCC models improves survival, suggesting potential for TSPAN16-based therapies .
TSPAN16 mutations are implicated in:
| Disease | OMIM Entry | Pathological Role | Source |
|---|---|---|---|
| Spastic Paraplegia 87 | 617580 | Axonal degeneration in the spinal cord | |
| Agenesis of Corpus Callosum | N/A | Neural migration defects |
Human Tetraspanin-16 belongs to the tetraspanin superfamily of membrane proteins that span the membrane four times. Like other tetraspanins, TSPAN16 likely consists of four transmembrane domains, two extracellular loops (EC1 and EC2), and short intracellular N- and C-terminal tails . The EC2 domain is particularly important as it confers specificity to individual tetraspanin members and is involved in most protein-protein interactions. Structural analysis of other tetraspanins has shown that EC2 domains typically contain approximately 50% α-helical content, as demonstrated for CD9 and CD81 EC2 domains . To characterize TSPAN16's structure, researchers typically employ circular dichroism (CD) spectroscopy, X-ray crystallography, or cryo-electron microscopy depending on the specific structural elements being investigated.
Recombinant TSPAN16 is produced through genetic engineering by inserting the TSPAN16 gene into a host organism for expression, whereas native TSPAN16 is naturally expressed in human cells . Key differences include:
Post-translational modifications: Recombinant proteins may lack proper glycosylation patterns or other modifications depending on the expression system used (bacterial, mammalian, insect, or yeast cells) .
Protein tags: Recombinant TSPAN16 is often produced with fusion tags such as His-tag or rho-1D4 tag to facilitate purification and detection .
Folding quality: Expression systems affect protein folding; mammalian systems generally produce better-folded tetraspanin proteins compared to bacterial systems, which may have inferior folding and potential LPS contamination .
Functional domains: Recombinant TSPAN16 often consists of specific domains (particularly the EC2 domain) rather than the full-length protein, which affects functional properties .
Multiple expression systems can be employed for TSPAN16 production, each with distinct advantages:
| Expression System | Advantages | Limitations | Applications |
|---|---|---|---|
| Bacterial (E. coli) | High yield, cost-effective, rapid production | Limited post-translational modifications, potential LPS contamination, inferior folding | EC2 domain studies, antibody production |
| Mammalian (HEK293, CHO) | Proper folding, post-translational modifications, native-like structure | Lower yield, higher cost, longer production time | Functional studies, structural analysis |
| Insect (Sf9, Hi5) | Higher yield than mammalian, some post-translational modifications | More costly than bacterial, different glycosylation patterns | Structural studies, protein-protein interactions |
| Yeast (P. pastoris) | High yield, some post-translational modifications | Hyperglycosylation, different glycosylation pattern | Large-scale production of EC2 domains |
Bacterial expression systems have been successfully used for producing tetraspanin EC2 domains, although challenges with protein folding have been noted . For full structural and functional studies, mammalian expression systems may be preferred despite difficulties reported in some expression attempts .
For successful expression and purification of recombinant TSPAN16, researchers should consider:
Expression optimization:
Bacterial expression: Use BL21(DE3) or Rosetta strains with induction at OD600 of 0.6-0.8 using 0.1-1.0 mM IPTG at 16-25°C for 16-20 hours to reduce inclusion body formation .
Mammalian expression: Transfect HEK293T cells using lipid-based transfection reagents or calcium phosphate methods with expression for 48-72 hours in serum-free media for cleaner purification .
Purification strategy:
For His-tagged TSPAN16: Use immobilized metal affinity chromatography (IMAC) with nickel or cobalt resins, followed by size exclusion chromatography .
For GST-fusion proteins: Utilize glutathione-agarose columns with careful optimization of tag removal using thrombin or PreScission protease .
Buffer conditions: Include 0.03-0.1% mild detergents (DDM, CHAPS) for full-length protein or PBS with reducing agents for EC2 domains .
Purification success should be verified through SDS-PAGE, Western blotting, and mass spectrometry to confirm protein identity and purity.
Several complementary approaches can verify TSPAN16 functional integrity:
Structural validation:
Functional assays:
Protein-protein interaction studies using pull-down assays, co-immunoprecipitation, or surface plasmon resonance
Cell-based functional assays examining effects on adhesion, migration, or fusion processes
Evaluation of binding to known tetraspanin partners using ELISA or biolayer interferometry
Quality control markers:
Monodispersity analysis using dynamic light scattering
Endotoxin testing, particularly for bacterially expressed proteins
Confirmation of expected post-translational modifications by mass spectrometry
Each validation method provides complementary information about protein quality and function.
Investigating TSPAN16 in the context of tetraspanin enriched microdomains requires sophisticated approaches:
Membrane reconstitution systems:
Live-cell imaging approaches:
Express fluorescently tagged TSPAN16 in cell lines
Use single-particle tracking or FRAP (Fluorescence Recovery After Photobleaching) to analyze dynamics within TEMs
Apply proximity ligation assays to detect TSPAN16 associations with partner proteins in situ
Proteomics analysis:
Use chemical crosslinking followed by mass spectrometry to identify TSPAN16 interaction partners
Compare TSPAN16-associated protein complexes under different cellular conditions
Apply quantitative proteomics to measure changes in TEM composition upon TSPAN16 manipulation
These approaches collectively provide insights into how TSPAN16 contributes to tetraspanin web functionality, which underlies its biological roles in bringing together proteins to form functional clusters .
While specific roles of TSPAN16 in immune regulation are not directly mentioned in the search results, comparison with other tetraspanin functions suggests potential mechanisms:
Receptor clustering and signaling:
Immune cell trafficking and adhesion:
TSPAN16 might regulate leukocyte migration through interactions with integrins or adhesion molecules
Methodology: Examine effects of recombinant TSPAN16 on immune cell adhesion, migration, and transmigration in transwell or 3D matrix systems
Antigen presentation:
Potential roles in MHC protein clustering and immunological synapse formation
Experimental design: Investigate TSPAN16 localization during antigen presentation using high-resolution imaging and functional consequences of TSPAN16 knockdown/overexpression
Tumor immunology applications:
Based on other tetraspanins' roles in cancer immunity, TSPAN16 may have prognostic value in tumors
Research approach: Analyze TSPAN16 expression patterns in tumor tissues and correlate with immune infiltration markers, similar to how other tetraspanin-related genes have been used in cancer prognosis models
When faced with contradictory data on TSPAN16 function, researchers should implement the following experimental design strategies:
Systematic validation across multiple systems:
Compare TSPAN16 functions across different cell types and species
Use both recombinant protein addition and genetic manipulation approaches (CRISPR/Cas9, siRNA, overexpression)
Verify antibody specificity using knockout controls and multiple detection methods
Control for technical variables:
Context-dependent function analysis:
Examine TSPAN16 function under different activation states
Test TSPAN16 in both isolated systems and complex environments
Consider temporal dynamics of TSPAN16 involvement in cellular processes
Reproducibility framework:
Implement blinded experimental design
Use multiple orthogonal techniques to address the same question
Apply appropriate statistical analyses with consideration of biological vs. technical replicates
A comprehensive multi-system approach helps resolve contradictions by identifying context-specific functions and technical artifacts.
Tetraspanin-16 can be distinguished from other family members through several key characteristics:
Structural comparison:
While all tetraspanins share the four-transmembrane domain architecture, TSPAN16's EC2 domain likely contains unique structural elements that differ from the better-characterized CD9, CD63, CD81, and CD151
Conserved cysteine patterns in EC2 domains are critical for proper disulfide bonding and folding; analysis of these patterns can reveal TSPAN16's subfamilial classification
Functional distinctions:
Expression pattern differences:
TSPAN16 exhibits tissue-specific expression that differs from ubiquitously expressed tetraspanins like CD81
This restricted expression pattern may indicate specialized functions in particular tissues
Evolutionary conservation:
Comparative sequence analysis across species can reveal TSPAN16-specific conserved motifs distinct from other tetraspanins
These uniquely conserved regions often correlate with specialized functions
Understanding these differences is critical for targeting TSPAN16-specific functions without affecting other tetraspanin family members.
Several computational strategies can predict TSPAN16 interaction partners:
Protein-protein interaction prediction:
Apply machine learning algorithms trained on known tetraspanin interactions
Use structural docking simulations focusing on the EC2 domain of TSPAN16
Analyze conservation patterns to identify potential interaction interfaces
Co-expression network analysis:
Mine RNA-seq databases to identify genes consistently co-expressed with TSPAN16
Apply weighted gene correlation network analysis (WGCNA) to identify functional modules containing TSPAN16
Use these networks to predict cellular pathways involving TSPAN16
Domain-based approaches:
Identify proteins containing domains known to interact with tetraspanin EC2 regions
Apply motif-based searches for proteins containing sequences complementary to TSPAN16-specific regions
Integration with experimental data:
Combine computational predictions with proteomics datasets
Filter predictions based on subcellular co-localization
Validate top candidates experimentally using co-immunoprecipitation or proximity labeling techniques
These bioinformatics approaches provide testable hypotheses about TSPAN16 functional partners that can guide experimental design.
Researchers should be aware of these common challenges and their solutions:
Expression and purification issues:
Problem: Poor expression yields
Solution: Optimize codon usage for expression system, test different promoters, and expression conditions
Problem: Protein aggregation
Solution: Express at lower temperatures (16-20°C), include solubility enhancers like sorbitol or arginine, and optimize detergent selection for membrane protein extraction
Functional assessment challenges:
Problem: Distinguishing specific from non-specific effects
Solution: Include appropriate controls (other tetraspanin EC2 domains, denatured protein, tag-only controls)
Problem: LPS contamination in bacterial preparations
Solution: Include endotoxin removal steps, verify endotoxin levels, and include polymyxin B controls in functional assays
Antibody-related issues:
Problem: Limited availability of specific anti-TSPAN16 antibodies
Solution: Validate commercial antibodies thoroughly, consider generating new antibodies using recombinant TSPAN16 as immunogen, or use epitope tagging strategies
Reproducibility concerns:
Problem: Batch-to-batch variation
Solution: Implement rigorous quality control measures, maintain detailed documentation of production methods, and establish minimum acceptance criteria for each protein batch
Addressing these challenges systematically improves research reliability and facilitates cross-laboratory reproducibility.
Investigating TSPAN16 within TEMs requires specialized methodologies:
Membrane isolation and analysis:
Use detergent resistance analysis with mild detergents (CHAPS, Brij series) to preserve tetraspanin-tetraspanin interactions
Apply sucrose gradient ultracentrifugation to separate TEM fractions
Analyze TSPAN16 distribution across fractions by immunoblotting
Compare TSPAN16-containing TEMs with those containing other tetraspanins like CD9, CD63, CD81, and CD151
Advanced imaging techniques:
Implement super-resolution microscopy (STORM, PALM) to visualize TEM organization below the diffraction limit
Use multi-color imaging to assess co-localization between TSPAN16 and potential partners
Apply FRET or BRET to measure protein proximities within TEMs
Consider lattice light-sheet microscopy for dynamic studies of TEM formation and reorganization
Functional disruption strategies:
Apply EC2 domains as competitive inhibitors of tetraspanin interactions
Use CD spectroscopy to confirm proper folding of recombinant EC2 domains before functional studies
Design specific mutations in TSPAN16 to disrupt TEM formation without affecting protein expression
Compare phenotypic effects of TSPAN16 perturbation with disruption of other tetraspanins
These approaches collectively provide insights into TSPAN16's specific contributions to TEM organization and function.
Building on known tetraspanin roles, TSPAN16 may contribute to disease through several mechanisms:
Cancer biology:
Potential involvement in tumor progression by modulating tumor immunity, similar to other tetraspanin-related genes that have demonstrated prognostic value in lung adenocarcinoma
Possible roles in metastasis through regulation of cell adhesion, migration, and invasion
Research direction: Analyze TSPAN16 expression patterns across cancer types and correlate with clinical outcomes and immune infiltration profiles
Immunological disorders:
Potential involvement in allergic responses through regulation of IgE-mediated degranulation, similar to CD9, CD63, CD81, and CD151
Possible contributions to inflammatory processes through modulation of leukocyte migration
Experimental approach: Examine TSPAN16 expression and function in relevant immune cell populations from patients with autoimmune or inflammatory conditions
Neurological conditions:
Tetraspanins regulate neuronal development and function; TSPAN16 might have specialized roles
Research strategy: Investigate TSPAN16 expression in neuronal tissues and potential contributions to neuronal signaling, synapse formation, or myelination
Infectious diseases:
Tetraspanins can serve as co-receptors for pathogens; TSPAN16 might play similar roles
Research approach: Screen for pathogen interactions with recombinant TSPAN16 and assess effects of TSPAN16 manipulation on infection models
These hypotheses can guide targeted investigations into TSPAN16's pathophysiological relevance.
Several cutting-edge approaches hold promise for TSPAN16 research:
Advanced structural biology techniques:
Cryo-electron microscopy for visualization of TSPAN16 in membrane contexts
Single-particle analysis to resolve conformational states
Integrative structural biology combining multiple data types (NMR, X-ray, molecular dynamics)
Genome editing and screening approaches:
CRISPR-Cas9 screens to identify genetic interactions with TSPAN16
Base editing to introduce specific TSPAN16 mutations without disrupting expression
Prime editing for precise modification of TSPAN16 regulatory elements
Single-cell technologies:
Single-cell proteomics to profile TSPAN16 expression at the protein level across cell types
Single-cell interactomics to map TSPAN16 protein interactions in individual cells
Spatial transcriptomics to visualize TSPAN16 expression patterns in tissue contexts
Microfluidic and organoid systems:
Organ-on-chip models incorporating TSPAN16-manipulated cells
Patient-derived organoids to study TSPAN16 function in disease-relevant contexts
Microfluidic co-culture systems to assess TSPAN16's role in cell-cell communication
These technologies will enable more precise and physiologically relevant investigations of TSPAN16 biology.